EarliPoint System uses eye tracking to support clinician assessments of childhood autism.
Competing Products
EarliPoint Health
EarliTec Diagnostics: Pioneering digital health solutions for early ASD detection and treatment.
Founded
2019EarliTec Diagnostics: Pioneering digital health solutions for early ASD detection and treatment.
EarliTec Diagnostics, founded by leading researchers at Children’s Healthcare of Atlanta, Emory University School of Medicine, and Yale University, is a digital health company dedicated to the early identification and treatment of Autism Spectrum Disorder (ASD) and related disabilities. Their core mission is to make early diagnosis and intervention accessible to children globally. EarliTec's flagship product, EarliPoint, is an FDA-authorized tool that monitors and analyzes children's looking behavior through video scenes of social interactions, providing clinicians with robust data for confident and objective diagnoses.
Notable affiliated individuals include researchers from prestigious institutions like Emory University and Yale University. EarliTec has garnered significant attention for its innovative approach, receiving FDA authorization for EarliPoint, which underscores its clinical reliability. The company has made a substantial impact by empowering healthcare providers with precise diagnostic tools, thereby improving early intervention outcomes for children with ASD.
Companies similar to EarliPoint Health include Cognoa, Otologic Technologies, Regard and SynapDx.
EarliPoint Health was founded in 2019.
EarliPoint Health's headquarters is located in Decatur, GA, US.
EarliPoint Health's most recent funding round was for $19.5M (USD) in February 2022.
As of Feb 18, 2022, EarliPoint Health has disclosed funding of $19.5M (USD). Undisclosed round amounts are excluded.
EarliPoint Health has 26 employees as of Feb 5, 2024.
SynapDx
